The following table summarizes the financial results of discontinued operations reflected in the Condensed Consolidated Statements of Income (Loss) for the three and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | (In thousands) | 2026 | | 2025 | | 2026 | | 2025 | | Costs and expenses | | | | | | | | | Selling, general and administrative | $ | 38 | | | $ | 97 | | | $ | 35 | | | $ | 325 | | | Gain on the sale of divested business | — | | | — | | | (565) | | | (9,657) | | | Total | 38 | | | 97 | | | (530) | | | (9,332) | | | Income (loss) from discontinued operations before income tax | (38) | | | (97) | | | 530 | | | 9,332 | | Income tax expense (benefit)1 | (8) | | | — | | | (31) | | | — | | | Income (loss) from discontinued operations, net of tax | $ | (30) | | | $ | (97) | | | $ | 561 | | | $ | 9,332 | | 1. An inconsequential income tax expense (benefit) was recognized during the three and six months ended June 30, 2025, primarily due to foreign tax credits generated from the final Brazilian withholding tax payment made during the periods, which offset the tax liability on the income from discontinued operations. |
The following table provides significant operating, investing and financing cash flow information for discontinued operations: | | | | | | | | | | | | | Six Months Ended June 30, | | (In thousands) | 2026 | | 2025 | | Operating activities: | | | | | Gain on the sale of divested business | $ | (565) | | | $ | (9,657) | | | Total | $ | (565) | | | $ | (9,657) | | | Investing activities: | | | | | Proceeds from the sale of Terphane | $ | 565 | | | $ | 9,835 | | | Total | $ | 565 | | | $ | 9,835 | |
|